Open access
Aug 2026
Myeloid landscape of BRAF-mutant papillary thyroid cancer and thyroiditis
The data suggest that LT in thyroid cancer is associated with enhanced antigen presentation and fewer features of pro-tumourigenic innate immune activity, which suggest new mechanisms to target immune treatments in PTC refractory to other therapies.
S. Perampalam, M. Gild, Sey Adwoa Amoakowa et al.
· Endocrine-Related Cancer · 0 citations